Scholars Central

Conference abstractPublished 23 Sep 2013

Accelerating biosimilar/biobetter development in Asia-A CRO/CMO perspective

Authors: Shude Yan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

With an increasing number of "blockbuster" level biopharmaceutical patents about to expire, and with strong government support of the sector, China presents a huge market for biosimilars. However, the competition will also be equally harsh. How to differentiate your product will be major challenge, so biobetters with a clear advantage from a spectrum of generics will become new opportunities of the future. Furthermore, the timing to enter the market will be critical for the commercial success of the drug, thus it may be a good idea to directly develop a second generation drug when similar drugs against the same target are still waiting to be approved. In recently years, China is gradually closing the technology gap with the developed nations in biologics drug development. In Shanghai, we have developed a platform to rapidly generate biobetters or second generation drugs with fully human sequence, higher affinity, and potentially better PK and other drug properties. We have also achieved high-efficiency cell line engineering, as well as large scale production of biologics including ADC (antibody drug conjugate). This provides a general platform to help biopharma accelerate the development of biosimilar, biobetter or innovator drugs in China and abroad.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Shude Yan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels